Top Markets
Coin of the day
Synmosa Biopharma Corporation Synmosa Biopharma Corporation

Synmosa Biopharma Corporation

4114
Rangering i aksjer #13190
Synmosa Biopharma Corporation, established in Taipei, Taiwan, in 1980, operates... Synmosa Biopharma Corporation, established in Taipei, Taiwan, in 1980, operates as a dedicated specialty pharmaceutical enterprise. The company manages the entire lifecycle of pharmaceutical and healthcare products, from research and development to manufacturing, marketing, and distribution, primarily serving the Taiwanese market under its proprietary Synmosa brand. Its diverse product portfolio addresses key therapeutic categories, including cardiovascular health, respiratory conditions, urology, sex hormone treatments, and oncology. These offerings are available in various formats such as effervescent tablets, granules, nasal sprays, metered-dose inhalers, hormonal preparations, and other specialized forms. Beyond its proprietary products, Synmosa also extends its expertise through contract manufacturing services. The company maintains a significant international presence, exporting its goods to numerous countries including South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua.
Aksjekurs
$0.94761103
Markedsverdi
$511.40M
Endring (1 dag)
-0.33%
Endring (1 år)
-9.95%
Land
TW
Handel Synmosa Biopharma Corporation (4114)

Kategori

Inntekter for Synmosa Biopharma Corporation (4114)
Inntekter i 2026 TTM: 0
Ifølge Synmosa Biopharma Corporation sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Synmosa Biopharma Corporation fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter